Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jingbin Zhang
Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image-Guided Radiotherapy Without Hormone Therapy
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Related publications
Evaluation of the Effectiveness of Adding Androgen Deprivation to Modern Dose-Escalated Radiotherapy for Men With Favorable Intermediate-Risk Prostate Cancer
Cancer
Cancer Research
Oncology
Target Localization and Toxicity in Dose-Escalated Prostate Radiotherapy With Image-Guided Approach Using Daily Planar Kilovoltage Imaging
Technology in Cancer Research and Treatment
Medicine
Cancer Research
Oncology
Intermediate Risk Prostate Cancer Patients Treated With Image Guided Hypofractionated Radiation Therapy
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
The Need for Androgen Deprivation Therapy in Patients With Intermediate-Risk Prostate Cancer Treated With Dose-Escalated External Beam Radiation Therapy
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Image-Guided Therapies for Prostate and Kidney Cancers
World Journal of Urology
Urology
Clinical Outcomes of Dose-Escalated Radiotherapy for Localised Prostate Cancer: A Single-Institution Experience
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
Salvage Image-Guided Radiotherapy to the Prostate After Cryotherapy Failure
Advances in Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Dose Tracking Assessment for Image-Guided Radiotherapy of the Prostate Bed and the Impact on Clinical Workflow
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Efficacy and Toxicity of Image-Guided Intensity-Modulated Radiation Therapy Combined With Dose-Escalated Brachytherapy for Stage IIB Cervical Cancer
Oncotarget
Oncology
